55. Relapsing polychondritis
7 clinical trials,   10 drugs   (DrugBank: 9 drugs),   12 drug target genes,   98 drug target pathways

Searched query = "Relapsing polychondritis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01272856
(ClinicalTrials.gov)
January 20116/1/2011Study on the Safety of Abatacept in Relapsing PolychondritisAn Open-Label, Single-Center, Phase I Study on the Safety of Abatacept in Relapsing PolychondritisRelapsing PolychondritisDrug: AbataceptBenaroya Research InstituteBristol-Myers SquibbCompleted18 Years80 YearsBoth4Phase 1United States